Browse Items (2 total)
- Tags: thrombolysis
Diurnal Variations in the First 24/7 Mobile Stroke Unit
Tags: 2019, Calderon V J, Cardiovascular System & Cardiology, Changal K H, de Havenon A, Department of Internal Medicine, diurnal variation, experience, Goins-Whitmore J, Lin E, mobile stroke unit, NEOMED College of Medicine, Neurosciences & Neurology, Patterson M S, prehospital stroke, September 2019 Update, stroke, Sultan-Qurraie A, system of care, Telemedicine, thrombolysis, Time, Zaidat O O
Safe Readministration of Intravenous Thrombolysis in Recurrent Basilar Thrombosis.
Tags: 2018, Aged, Basilar Artery, Basilar Artery – Drug Effects, Basilar Artery – Physiopathology, Basilar Artery/diagnostic imaging/*drug effects/physiopathology, Cerebral Angiography – Methods, Cerebral Angiography/methods, Computed Tomography Angiography, Department of Internal Medicine, Drug Administration Schedule, Fibrinolytic Agents – Administration and Dosage, Fibrinolytic Agents – Adverse Effects, Fibrinolytic Agents/*administration & dosage/adverse effects, Humans, Infusions, Intracranial Thrombosis, Intracranial Thrombosis – Drug Therapy, Intracranial Thrombosis – Physiopathology, Intracranial Thrombosis/diagnostic imaging/*drug therapy/physiopathology, Intravenous, Itrat Ahmed, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, Khan Alina, Magnetic Resonance Imaging, Male, medication safety, NEOMED College of Medicine, Recombinant Proteins – Administration and Dosage, Recombinant Proteins/administration & dosage, Recurrence, recurrent stroke, Repeat Procedures, Retreatment, thrombolysis, Thrombolytic Therapy – Adverse Effects, Thrombolytic Therapy – Methods, Thrombolytic Therapy/adverse effects/*methods, Thrombosis, Time Factors, Tissue Plasminogen Activator – Administration and Dosage, Tissue Plasminogen Activator – Adverse Effects, Tissue Plasminogen Activator/*administration & dosage/adverse effects, Treatment Outcome, Treatment Outcomes